These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells. Ahmad US; Parkinson EK; Wan H Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271 [TBL] [Abstract][Full Text] [Related]
4. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
5. TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148 [TBL] [Abstract][Full Text] [Related]
6. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma. Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049 [TBL] [Abstract][Full Text] [Related]
7. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase. Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328 [TBL] [Abstract][Full Text] [Related]
8. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. Lo Sardo F; Forcato M; Sacconi A; Capaci V; Zanconato F; Di Agostino S; Del Sal G; Pandolfi PP; Strano S; Bicciato S; Blandino G Carcinogenesis; 2017 Jan; 38(1):64-75. PubMed ID: 27797825 [TBL] [Abstract][Full Text] [Related]
9. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of YAP, TAZ, TEAD4 and p73 in human laryngeal cancer. Tsinias G; Nikou S; Mastronikolis N; Bravou V; Papadaki H Histol Histopathol; 2020 Sep; 35(9):983-995. PubMed ID: 32378727 [TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261 [TBL] [Abstract][Full Text] [Related]
12. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis. Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528 [TBL] [Abstract][Full Text] [Related]
13. YAP and TAZ are essential for basal and squamous cell carcinoma initiation. Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149 [TBL] [Abstract][Full Text] [Related]
14. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258 [TBL] [Abstract][Full Text] [Related]
15. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. Kim J; Kwon H; Shin YK; Song G; Lee T; Kim Y; Jeong W; Lee U; Zhang X; Nam G; Jeung HC; Kim W; Jho EH Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13529-13540. PubMed ID: 32482852 [TBL] [Abstract][Full Text] [Related]
16. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276 [TBL] [Abstract][Full Text] [Related]
17. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell. Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma. Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745 [No Abstract] [Full Text] [Related]
19. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma. Zhang L; Ye DX; Pan HY; Wei KJ; Wang LZ; Wang XD; Shen GF; Zhang ZY Oral Oncol; 2011 Aug; 47(8):693-7. PubMed ID: 21708480 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma]. Tu MS; Li YS; Zhang X Shanghai Kou Qiang Yi Xue; 2018 Aug; 27(4):415-418. PubMed ID: 30483712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]